New ETF Tracks Developers of Obesity Drugs Amid Ozempic Hype

The Tema Cardiovascular and Metabolic ETF (HRTS) tracks companies involved in the treatment of cardio-metabolic diseases.

Related Keywords

United States ,American ,Tema Etfs ,Eli Lilly ,Novo Ozempic ,Athanasios Psarofagis ,Novo Nordisk ,Arrowhead Pharmaceuticals Inc ,Pharma Inc ,Eli Lilly Co ,Tema Cardiovascular ,Arrowhead Pharmaceuticals ,Bridgebio Pharma Inc ,Maurits Pot ,Shares Biotechnology ,David Song ,Bloomberg Intelligence ,